Last update 24 May 2025

IL-18 armored U5 snRNP200 CAR-T(MSKCC)

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
IL18R1 x SNRNP200
Action
agonists, inhibitors
Mechanism
IL18R1 agonists(Interleukin 18 receptor agonists), SNRNP200 inhibitors(small nuclear ribonucleoprotein U5 subunit 200 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Acute Myeloid LeukemiaPre B-cell acute lymphoblastic leukemia
Inactive Indication-
Originator Organization
Envisagenics, Inc.Envisagenics, Inc.
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
Active Organization
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer CenterEnvisagenics, Inc.Envisagenics, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with IL-18 armored U5 snRNP200 CAR-T(MSKCC)
Login to view more data
100 Translational Medicine associated with IL-18 armored U5 snRNP200 CAR-T(MSKCC)
Login to view more data
100 Patents (Medical) associated with IL-18 armored U5 snRNP200 CAR-T(MSKCC)
Login to view more data
100 Deals associated with IL-18 armored U5 snRNP200 CAR-T(MSKCC)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPreclinical
United States
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
07 Dec 2024
Acute Myeloid LeukemiaPreclinical
United States
Envisagenics, Inc.Envisagenics, Inc.
07 Dec 2024
Pre B-cell acute lymphoblastic leukemiaPreclinical
United States
Envisagenics, Inc.Envisagenics, Inc.
07 Dec 2024
Pre B-cell acute lymphoblastic leukemiaPreclinical
United States
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
07 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free